Upstream Bio

Price & Volume

Track all markets on TradingView

Stats

See more
52W Range
$5.14-$29.46
Market Cap
$1B
Shares Short
3M

Financials

See more
Revenue (12 Mos)
$2.7M
Revenue Growth (YoY)
83.7%
Gross Profit (12 Mos)
$2.7M
Diluted EPS
-$6.73

News

See more

Yahoo Finance • 2 days ago

Upstream Bio Presents Data Showing Structural and Mechanistic Drivers of Verekitug’s Potent Pharmacodynamic Activity and Differentiated Clinical Profile at European Respiratory Society Congress

Yahoo Finance • 23 days ago

Upstream Bio to Participate in the Stifel 2025 Virtual Immunology and Inflammation Forum

Yahoo Finance • 30 days ago

Upstream Bio Reports Positive Top-line Results From Phase 2 VIBRANT Study

Yahoo Finance • 30 days ago

Upstream Bio Reports Positive Top-Line Results from the Phase 2 VIBRANT Trial of Verekitug for the Treatment of Chronic Rhinosinusitis with Nasal Polyps (CRSwNP)

About

CEO
Dr. E. Rand Sutherland M.D., M.P.H., MPH
CFO
Mr. Michael Paul Gray CPA, MBA
Address
890 Winter Street, Waltham, MA, United States, 02451
Sector
Healthcare
Industry
Biotechnology
Full-Time Employees
52